Equitable Financial Corp. (EQFN)

Ligand Pharmaceuticals Revenue

Equitable Financial had revenue of $4.64M in the quarter ending March 31, 2025, a decrease of -0.89%. In the fiscal year ending June 30, 2023, Equitable Financial had annual revenue of $19.43M, down -5.17%.

• Revenue: 19.43M
• Revenue Growth: -5.17%
• P/S Ratio: n/a
• Revenue / Employee: n/a
• Employees: n/a
• Market Cap: 30.54M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Jun 30, 2023	19.43M	-1.06M	-5.17%
Jun 30, 2022	20.49M	459.91K	2.30%
Jun 30, 2021	20.03M	3.78M	23.23%
Jun 30, 2020	16.26M	2.85M	21.28%
Jun 30, 2019	13.40M	1.92M	16.67%